Sophisticated Diagnostic Procedures Spurs Non-alcoholic Steatohepatitis Therapeutics in Asia Pacific Markets

2019-01-15 // 0 Comments

Albany, US, 2019-Jan-15 — /EPR Network/ —Rampant prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to propel the nonalcoholic steatohepatitis therapeutics market. Non-alcoholic steatohepatitis [read full press release…]

Non-alcoholic steatohepatitis Market: Up Surge in Number of People Suffering from Obesity and Diabetes to Propel Demand

2018-11-23 // 0 Comments

Albany, US, 2018-Nov-23 — /EPR Network/ — The nonalcoholic fatty liver diseases (NAFLD) at times may lead to nonalcoholic steatohepatitis (NASH), which is a chronic [read full press release…]